Nectar Lifesciences Limited
₹35.26
INR+0.69(+2.00%)
As of November 14, 2024 10:00:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹808.83 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹1382.66 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
133.07
Forward P/E
Price to Earnings ratio based on forecasted earnings
12.10
PEG Ratio
Price/Earnings to Growth ratio
12.10
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
0.49
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
33.86%
Operating Margin
Operating income as a percentage of revenue
6.78%
Return on Equity
Net income as a percentage of shareholders' equity
0.47%
Revenue (TTM)
Total revenue over trailing 12 months
₹1649.30 Cr-8.9%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹172.31 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹0.27+63.1%
Balance Sheet
Total Cash
Total cash and short-term investments
₹20.30 Cr
Total Debt
Total short-term and long-term debt
₹635.54 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
59.44%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹22.8 - ₹56.5
Beta
Measure of stock's volatility compared to the market
1.01
Shares Outstanding
Total number of shares issued by the company
₹22.43 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
0.53%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
0.00%
Payout Ratio
Percentage of earnings paid as dividends
0.00%